Condition
Pancreatic Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 17 Pancreatic Neoplasm clinical trials that are recruiting, at sites in 14 countries (most in United States (8), South Korea (3), Taiwan (2)). By phase: Phase 2 (3), Phase 1 (2), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 14Countries
Newest Pancreatic Neoplasm clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How hormone and digestion functions and outcomes change after pancreas surgery | — | Taipei, Taiwan | Recruiting | Feb 9, 2026 |
| Slow stomach emptying after pancreatic surgery | — | Taipei, Taiwn | Recruiting | Feb 3, 2026 |
| Carbon ion radiotherapy for frail people with pancreatic cancer | Phase 2 | Seoul | Recruiting | Dec 2, 2025 |
| Using ctDNA methylation to guide prognosis and monitoring in pancreatic cancer | — | Shanghai, Shanghai Municipality | Recruiting | Jul 1, 2025 |
| Lanreotide versus placebo before surgery to prevent a pancreatic fistula | Phase 3 | Birmingham, Alabama and 117 other locations | Recruiting | Feb 4, 2025 |
| Using MRI to Diagnose Pancreatic Masses | — | Shenyang, Liaoning | Recruiting | Jul 29, 2024 |
| Comparing two pain relief methods after pancreas surgery | Phase 2 | Minneapolis, Minnesota | Recruiting | May 13, 2024 |
| Evaluating LY4170156 for advanced solid tumors | Phase 1 | Scottsdale, Arizona and 24 other locations | Recruiting | May 6, 2024 |
| Screening for pancreatic cancer in high-risk individuals | Early Phase 1 | Boston, Massachusetts and 1 other locations | Recruiting | Nov 8, 2023 |
| Evaluating a new CAR T-cell therapy for solid tumors expressing MSLN | Phase 1/2 | Gilbert, Arizona and 11 other locations | Recruiting | Sep 25, 2023 |
All recruiting trials (17)
-
How hormone and digestion functions and outcomes change after pancreas surgery
This project will look back at medical records to see if different pancreatectomy methods, margin clearance, and how much pancreas is left affect hormone (endocrine) and digestion (exocrine) function and overall outcomes in adults who had pancreas surgery at our hospital.
-
Slow stomach emptying after pancreatic surgery
We will look back at adults who had pancreatic surgery to see if surgical technique, use of a gastrointestinal feeding tube, how cleanly the tumor was removed, or the size of the remaining pancreas affect delayed stomach emptying.
-
Carbon ion radiotherapy for frail people with pancreatic cancer
This trial will try carbon ion radiotherapy as a treatment for people with non-metastatic pancreatic cancer who are too frail for surgery or standard chemotherapy.
-
Using ctDNA methylation to guide prognosis and monitoring in pancreatic cancer
This project tests whether a blood test that measures ctDNA methylation can help detect and monitor pancreatic cancer in adults who are undergoing surgery or biopsy.
-
Lanreotide versus placebo before surgery to prevent a pancreatic fistula
This trial will see if giving lanreotide before a planned distal pancreatectomy lowers the risk of a pancreatic fistula in adults with pancreatic cancer or a suspicious pancreatic lesion.
-
Using MRI to Diagnose Pancreatic Masses
This study is testing if a special MRI technique can help doctors better understand pancreatic cancer by measuring the stiffness of tumors to improve treatment decisions for patients.
-
Comparing two pain relief methods after pancreas surgery
This study is testing whether a new way of giving pain relief after pancreas surgery works just as well as the traditional method, to help patients feel better with fewer risks.
-
Evaluating LY4170156 for advanced solid tumors
This study is testing a new drug called LY4170156 to see if it is safe and effective for people with advanced solid tumors like ovarian and lung cancers.
-
Screening for pancreatic cancer in high-risk individuals
This study is testing if combining blood tests and symptom checks with regular screenings can help find pancreatic cancer earlier in people who are at higher risk because of their genetics.
-
Evaluating a new CAR T-cell therapy for solid tumors expressing MSLN
This study is testing a new CAR T-cell therapy to see if it can safely treat adults with solid tumors like colorectal and lung cancer that express a specific protein.
-
Endoscopic ultrasound-guided radiofrequency ablation for pancreatic tumors
This study is testing a new, less invasive treatment using ultrasound and heat to see if it can safely help people with pancreatic tumors, especially cystic neoplasms.
-
Combination of trastuzumab and pertuzumab for treating cancers with HER2 mutations
This study is testing if a combination of two cancer drugs, trastuzumab and pertuzumab, can help adults and young people with cancers that have HER2 mutations or amplifications.
-
Combining Sunitinib with Lutetium Lu 177 Dotatate for Pancreatic Neuroendocrine Tumors
This study is testing if combining two treatments, sunitinib and lutetium Lu 177 dotatate, can help people with advanced pancreatic neuroendocrine tumors live longer and feel better.
-
Using MRI to Improve Surgery Selection for Pancreatic Cancer Patients
This study is testing whether using MRI along with CT scans can help doctors better decide if surgery is a good option for pancreatic cancer patients with possible liver spread.
-
Preoperative chemotherapy with radiation for borderline resectable pancreatic cancer
This study is testing whether adding a specific type of radiation therapy to chemotherapy before surgery can help people with borderline resectable pancreatic cancer have better outcomes.
-
Registry for patients with unresectable pancreatic cancer treated with OncoSil™
This study is testing how well the OncoSil™ device works and its safety for people with advanced pancreatic cancer who are also receiving chemotherapy.
-
Comparing two ways to monitor pancreatic cysts
This trial tests whether more frequent or less frequent imaging is better for people aged 50–75 who have one or more pancreatic cysts ≥1 cm.
Related topics
Quick answers
How many Pancreatic Neoplasm clinical trials are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (8 trials), South Korea (3 trials), Taiwan (2 trials), Spain (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 2, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.